Pharmaceutical Manufacturing Virtual Panel – Using the Discrete Element Method (DEM) to simulate pharmaceutical manufacturing processes

Start Date
End Date

Join a live virtual panel presentation & discussion to hear insights from industry experts on the use of the Discrete Element Method (DEM) as a modelling tool for optimizing pharmaceutical manufacturing processes.

Speakers will take turn to discuss and share their experience and perspective around the following topics:

  • Challenges faced before introducing DEM simulation and why considered/adopted
  • Experience adopting DEM
  • Typical DEM applications in process and product development
  • Key benefits of using DEM
  • Regulatory framework: using models for regulatory purposes
  • Digital design / digital twin
  • Looking ahead for DEM: next focus and challenges ahead
  • How DEM can help fast and efficient drug development and manufacturing in the current context


  • Liang Li
    Process Engineering Scientist
    The Janssen Pharmaceutical Companies of Johnson & Johnson
  • Maitraye Sen
    Senior Consultant Engineer
    Eli Lilly and Company
  • Nima Yazdanpanah
  • Fernando Muzzio
    Distinguished Professor of Chemical and Biochemical Engineering
    Rutgers University

Who should attend?

  • Engineers, scientists and researchers involved in the drug product manufacturing process.
  • Anyone interested to learn more about the applications of the Discrete Element Method in the pharmaceutical industry, what key insight it can provide and the benefits it can bring to optimize drug development.

Find out more about the speakers and the agenda here.